Johnson & Johnson
Recent News About Johnson & Johnson
-
Johnson & Johnson hit with $247M verdict, thousands of more hip implant cases waiting in the wings
DALLAS – Six plaintiffs reaped a combined $247 million in damages following a trial against Johnson & Johnson over an allegedly defective hip implant device. -
Johnson & Johnson prevails in injury trial over pelvic mesh product
HOUSTON – A federal jury has found that there was no defect in a pelvic mesh product when it left the possession of Ethicon, a subsidiary of Johnson & Johnson. -
Some appreciate today’s medical marvels, others sue the makers
Christiaan Barnard performed the first heart transplant in 1967, just 50 years ago. Today, heart transplants are commonplace procedures, and artificial hearts and pacemakers also extend lives in ways medically impossible just a few decades ago. Transplants of other organs are now routine, too, as are the attachment of prosthetic limbs and the implantation of artificial joints. -
Johnson & Johnson 'remains committed' in battle against hip implant lawsuits
DALLAS – Medicinal-pharmaceutical corporate giant Johnson & Johnson Co. continues to battle more than 8,000 lawsuits made against the company over an allegedly defective hip implant device, and attorneys for the firm insist they are in the right despite continuing setbacks in a case that seems to have no end. -
DePuy and Johnson & Johnson appeal decision in favor of hip implant recipients
DALLAS – DePuy Orthopaedics and Johnson & Johnson have appealed a trial court decision that would have them pay out $150 million in damages to five plaintiffs. -
$1B verdict against Johnson & Johnson reinforces 'need for appellate review,' says attorney
DALLAS – A verdict of more than $1 billion has been handed down by a federal jury in a lawsuit regarding hip replacements. -
Third verdict issued in Johnson & Johnson, DePuy cases
DALLAS -- Another verdict has been handed down in one of the cases against Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc.